HOME >> BIOLOGY >> NEWS
Breast cancer and hormone therapy -- A looking-glass mirror?

The medical community has been debating for many years whether, and to what extent, postmenopausal hormone therapy (HT) use is associated with a higher risk of breast cancer, says Professor Amos Pines, President of the International Menopause Society. Although it is agreed that long-term HT slightly increases that risk, the definition of long-term use is still unclear, particularly in view of data showing that it may vary significantly by type of HT (estrogen-alone vs. estrogenprogestin, brand of progestin, dosage). A new study from the Kaiser Permanente health plan[1] raises the question whether trends in breast cancer incidence and use of HT over the past 25 years may be directly linked.

The Womens Health Initiative (WHI) trial was a landmark in menopause medicine since it provided information based on the best available study methodology[2]. By adopting its results as the ultimate source of information, many organizations, medical societies and health authorities actually declared that data derived from observations in the postmenopausal population are less valuable. Nevertheless, during the past few months, several studies have used databases on the incidence of breast cancer, on the one hand, and sales of HT on the other hand, in order to suggest a direct link between trends of hormone use and the number of newly diagnosed breast cancer patients. While such information, by itself, is very important and interesting, conclusions must be drawn with great caution. It is tempting to simplify the observed year-by-year figures on HT use and breast cancer incidence and establish a mirror glass equation: the more postmenopausal hormone use, the more breast cancer, and vice versa. But human biology is far too complicated and the pathophysiology of breast cancer is far too complex to adopt such a mechanistic approach, as the authors of those studies and related Editorials rightly say.

The mere fact that the incidence of lung cancer is higher among
'"/>

Contact: Jean Wright
jwright.ims@btopenworld.com
International Menopause Society
24-Jul-2007


Page: 1 2 3

Related biology news :

1. Breast cancer prognosis runs in the family
2. Breast cancer milieu -- Progression, tamoxifen sensitivity, and DNA reversion
3. Is bigger better? Breast surgery linked to boost in self-esteem and sexuality
4. Breast cancer treatment heats up
5. Genesearch Breast Lymph Node assay detects breast cancer metastases with greater sensitivity
6. Breast Cancer Month story tips from Georgetown University Medical Center
7. Breast density helps predict breast cancer risk
8. Breast stem cells have features similar to basal tumors
9. Breast cancer genetics and more -- press release from PLoS Medicine
10. Breast-sparing surgery an option for women with breast cancer gene mutation, U-M-led study finds
11. Breast implants not associated with cancer risk, study reports

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2019)... ... April 24, 2019 , ... ... Secretary Alex Azar today, a broad collective of 62 individual scientists, bioethicists, and ... Society of Gene & Cell Therapy (ASGCT), across industry and academia called for ...
(Date:4/17/2019)... FRANCISCO (PRWEB) , ... April 17, 2019 , ... ... data management, biostatistics, and other services to clinical trial sponsors, has entered into ... trials. The agreement will enable Quartesian, a member of Medrio’s Certified Partner Program, ...
(Date:4/16/2019)... (PRWEB) , ... April 16, 2019 , ... ... its featured speakers for two signature events: The 2019 ISPE Biopharmaceutical Manufacturing ... on 20–21 June. Taking place in one of the most influential bio ...
Breaking Biology News(10 mins):
(Date:4/18/2019)... ... April 18, 2019 , ... Taking a ... includes a chemical engineer at Worcester Polytechnic Institute (WPI) has developed a novel ... possible to manufacture isobutanol and other biofuels more economically. , Isobutanol, like ethanol, ...
(Date:4/15/2019)... Ohio (PRWEB) , ... April 15, 2019 , ... ... oligomers, has completed construction of a $2 million bench plant expansion to increase ... an important step in the design and construction of Sirrus’ full-scale production facility, ...
(Date:4/10/2019)... ... 2019 , ... After more than three months of renovation, Lajollacooks4u is set ... updated appliances and modern lighting and fixtures, and will provide additional workspace for the ... tremendous growth in the demand for our team-building events and cooking classes over the ...
(Date:4/9/2019)... ... 09, 2019 , ... The American Society of Gene & Cell Therapy ... including a new addition to the presidential line of succession, at the 22nd ... Society's leadership team for a three-year term (2019-2021). , All five incoming members of ...
Breaking Biology Technology:
Cached News: